FDA Inspection 1169722 — Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC — FEI 3008914686

The FDA completed an inspection of Dendreon Pharmaceuticals LLC on Apr 21, 2022 in Union City, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 21, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Union City, GA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.